GR860610B - Inter despersible and water soluble polymer compositions for parenteral administration - Google Patents

Inter despersible and water soluble polymer compositions for parenteral administration

Info

Publication number
GR860610B
GR860610B GR860610A GR860100610A GR860610B GR 860610 B GR860610 B GR 860610B GR 860610 A GR860610 A GR 860610A GR 860100610 A GR860100610 A GR 860100610A GR 860610 B GR860610 B GR 860610B
Authority
GR
Greece
Prior art keywords
despersible
inter
water soluble
soluble polymer
parenteral administration
Prior art date
Application number
GR860610A
Other languages
English (en)
Inventor
Cady Mancini Susan
Fishbein Richard
Schroder Ulf
Eriksson Hakan
Probasco Lee Brenda
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8501094A external-priority patent/SE8501094D0/xx
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GR860610B publication Critical patent/GR860610B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pens And Brushes (AREA)
  • Organic Insulating Materials (AREA)
GR860610A 1985-03-06 1986-03-05 Inter despersible and water soluble polymer compositions for parenteral administration GR860610B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8501094A SE8501094D0 (sv) 1985-03-06 1985-03-06 Biologiskt aktiv komposition och forfarande for framstellning derav
US71741785A 1985-03-29 1985-03-29
US83015886A 1986-02-20 1986-02-20

Publications (1)

Publication Number Publication Date
GR860610B true GR860610B (en) 1986-06-30

Family

ID=27355321

Family Applications (1)

Application Number Title Priority Date Filing Date
GR860610A GR860610B (en) 1985-03-06 1986-03-05 Inter despersible and water soluble polymer compositions for parenteral administration

Country Status (11)

Country Link
EP (1) EP0193917A3 (el)
KR (1) KR890004687B1 (el)
AU (1) AU591478B2 (el)
DK (1) DK100686A (el)
ES (1) ES8704347A1 (el)
FI (1) FI860923A (el)
GR (1) GR860610B (el)
IL (1) IL78031A0 (el)
NO (1) NO860832L (el)
NZ (1) NZ215366A (el)
PT (1) PT82150B (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US4857505A (en) * 1987-03-09 1989-08-15 American Cyanamid Company Sustained release compositions for parenteral administration and their use
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
DE3782737T3 (de) * 1987-08-21 1999-05-20 Imcera Group Inc Stabilisierung von Wachstumshormonen.
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
GB8725427D0 (en) * 1987-10-30 1987-12-02 Lilly Industries Ltd Somatotropin formulations
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
FR2637501A1 (fr) * 1988-10-07 1990-04-13 Inst Develop Valorisa Biotec Composition stabilisee a base de facteurs de croissance de la famille fgf et de dextrane sulfate, et ses applications
WO1990008551A1 (en) * 1989-01-26 1990-08-09 Damon Biotech, Inc. Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
AU653325B2 (en) * 1990-02-12 1994-09-29 Lucky Limited A composition durably releasing bioactive polypeptides
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
NZ234439A (en) * 1990-07-10 1997-08-22 Pharmacia & Upjohn Ab Use of igf-1 to reduce fetal growth retardation in non human mammals
US5714458A (en) * 1990-07-18 1998-02-03 Farmitalia Carlo Erba S.R.L. Stable pharmaceutical compositions containing a fibroblast growth factor
IE912345A1 (en) * 1990-08-03 1992-02-12 Pharmacia Ab Treatment of human lactation failure
GB9102107D0 (en) * 1991-01-31 1991-03-13 Erba Carlo Spa Stabilisation of fibroblast growth factor using a polysaccharide
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
JP3698721B2 (ja) * 1993-02-23 2005-09-21 ジェネンテク・インコーポレイテッド 有機溶媒を用いて処理したポリペプチドの賦形剤安定化
ZA949350B (en) 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
JP2003530367A (ja) 2000-04-05 2003-10-14 ヘルガソン・ハフスタイン 天然吸着剤を用いた化合物の回収方法
EP2700431A1 (en) 2012-08-24 2014-02-26 AnalytiCon Discovery GmbH Plant extracts for modulating TRPV1 function

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE396693B (sv) * 1970-02-16 1977-10-03 Paulsen Fredrik Sett att framstella komplex av syntetiskt kortikotropin med forsterkt och forlengd verkan
GB1345513A (en) * 1973-01-12 1974-01-30 Vosper Thornycroft Ltd Gas cushion vehicle
FR2265043A1 (en) * 1974-03-18 1975-10-17 Dietrich & Cie De Roasting oven with several spits - has single motor turning all spits together through common crank plate
DE2512943A1 (de) * 1974-04-02 1975-10-16 Sandoz Ag Verfahren zur herstellung protrahiert wirksamer injektionspraeparate
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
EP0123291A2 (en) * 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung

Also Published As

Publication number Publication date
AU5430686A (en) 1986-10-16
AU591478B2 (en) 1989-12-07
FI860923A (fi) 1986-09-07
KR890004687B1 (ko) 1989-11-25
NO860832L (no) 1986-09-08
DK100686D0 (da) 1986-03-05
DK100686A (da) 1986-09-07
EP0193917A3 (en) 1987-09-23
NZ215366A (en) 1988-07-28
PT82150A (en) 1986-04-01
PT82150B (pt) 1988-02-17
ES8704347A1 (es) 1987-04-01
FI860923A0 (fi) 1986-03-05
ES552690A0 (es) 1987-04-01
IL78031A0 (en) 1986-07-31
EP0193917A2 (en) 1986-09-10
KR860006985A (ko) 1986-10-06

Similar Documents

Publication Publication Date Title
GR860610B (en) Inter despersible and water soluble polymer compositions for parenteral administration
EP0262945A3 (en) Water soluble polymeric compositions
GB8615339D0 (en) Polysaccharide compositions
GB8514330D0 (en) Polymer composition
EP0172723A3 (en) Water soluble polymers
IL83462A0 (en) Compositions for parenteral administration and their use
NZ218440A (en) N-benzoylureas and anti-cancer compositions
GB8604849D0 (en) Polymer compositions
ZA868892B (en) Polymer composition
IL78930A0 (en) Lyophilized emulsion compositions for parenteral administration
DE3663145D1 (en) Propylene polymer composition
EP0230030A3 (en) Polymer composition
ZA866709B (en) Parenteral fluid administration set
EP0230744A3 (en) Propylene polymer composition
GB8612893D0 (en) Copolymer
GB2169302B (en) Polymer composition
GB8715228D0 (en) Polymer compositions
GB2192004B (en) Stabilized polymer compositions
GB8525284D0 (en) Polymer compositions
GR860684B (en) Polymer composition
GB8602861D0 (en) Breakwater
ZA861656B (en) Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
GB8506944D0 (en) Compositions comprising polymer
GB2179256B (en) Parenteral administration set
GB8612721D0 (en) Soluble polymer compositions